This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Rigel Pharmaceuticals Inc (RIGL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 20.85M 33.48M 18.63M 8.88M
Receivables 5.75M 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 220.08M 302.46M 250.23M 179.93M
Property, Plant & Equipment, Gross 26.84M 26.06M 23.10M 21.00M
Accumulated Depreciation & Depletion 22.38M 20.24M 18.22M 16.47M
Property, Plant & Equipment, Net 4.46M 5.83M 4.88M 4.53M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.53M 1.76M 1.99M 2.24M
Total Non-Current Assets 5.98M 7.58M 6.87M 6.77M
Liabilities & Shareholder Equity
Total Assets 226.06M 310.04M 257.11M 186.70M
Accounts Payable 3.90M 1.70M 1.56M 1.40M
Short Term Debt 0.00 0.00 0.00 755.00K
Other Current Liabilities 0.00 2.12M 0.00 0.00
Total Current Liabilities 10.29M 12.20M 11.53M 11.33M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 7.44M 8.65M 0.00 0.00
Other Non-Current Liabilities 74.00K 96.00K 9.43M 9.19M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 7.51M 8.74M 9.43M 9.24M
Total Liabilities 17.81M 20.95M 20.96M 20.56M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 208.25M 289.10M 236.15M 166.13M
Common Par 88.00K 87.00K 71.00K 52.00K
Additional Paid In Capital 1.06B 1.05B 897.48M 741.55M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -849.27M -760.25M -661.41M -575.43M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 47.00K 82.00K 6.00K -38.00K
Total Capitalization 208.25M 289.10M 236.15M 166.13M
Total Equity 208.25M 289.10M 236.15M 166.13M
Total Liabilities & Stock Equity 226.06M 310.04M 257.11M 186.70M
Total Common Shares Outstanding 87.52M 87.14M 71.38M 52.27M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 87.29M 74.97M 63.33M 52.06M
Diluted Weighted Shares Outstanding 87.29M 74.97M 63.33M 52.57M
Number of Employees 129 157 153 145
Number of Part-Time Employees 0 0 0 0
RIGL News

RIGL Rigel Pharmaceuticals Inc

Analysts Ratings for RIGL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET RIGL ANALYST REPORT

Brokerage Partners

RIGL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs